Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saba Sile

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Opinion in Nephrology and Hypertension|August 18, 2006
Molecular physiology of renal ClC chloride channels/transportersSaba Sile, Carlos G Vanoye, Alfred L George
Genetic Epidemiology|November 26, 2008
A likelihood ratio test of population Hardy-Weinberg equilibrium for case-control studiesChang Yu, Sanguo Zhang, Chuan Zhou, et al.
Heart Rhythm|April 27, 2005
Congenital long QT syndrome aggravated by salt-wasting nephropathyDawood Darbar, Saba Sile, Frank A Fish, et al.
The Lancet. Diabetes & Endocrinology|April 18, 2021
Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trialsGeorge J Kahaly, Raymond S Douglas, Robert J Holt, et al.
JIMD Reports|January 14, 2022
Cysteamine bitartrate delayed-release capsules control leukocyte cystine levels and promote statural growth and kidney health in an open-label study of treatment-naïve patients <6 years of age with nephropathic cystinosisMaria Helena Vaisbich, Juliana Caires Ferreira, Heather Price, et al.
Clinical Pharmacokinetics|March 26, 2021
Pharmacokinetics and Exposure-Response Relationship of Teprotumumab, an Insulin-Like Growth Factor-1 Receptor-Blocking Antibody, in Thyroid Eye DiseaseYan Xin, Fengyan Xu, Yuying Gao, et al.
Hypertension (Dallas, Tex. : 1979)|November 21, 2007
Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedemaJames Brian Byrd, Karine Touzin, Saba Sile, et al.
Human Heredity|July 27, 2007
Haplotype diversity in four genes (CLCNKA, CLCNKB, BSND, NEDD4L) involved in renal salt reabsorptionSaba Sile, Digna R Velez, Niloufar B Gillani, et al.
Journal of Hypertension|February 21, 2009
CLCNKB-T481S and essential hypertension in a Ghanaian populationSaba Sile, Digna R Velez, Niloufar B Gillani, et al.
American Journal of Hypertension|October 24, 2007
Functional BSND variants in essential hypertensionSaba Sile, Niloufar B Gillani, Digna R Velez, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Opinion in Nephrology and Hypertension|August 18, 2006
Molecular physiology of renal ClC chloride channels/transportersSaba Sile, Carlos G Vanoye, Alfred L George
Genetic Epidemiology|November 26, 2008
A likelihood ratio test of population Hardy-Weinberg equilibrium for case-control studiesChang Yu, Sanguo Zhang, Chuan Zhou, et al.
Heart Rhythm|April 27, 2005
Congenital long QT syndrome aggravated by salt-wasting nephropathyDawood Darbar, Saba Sile, Frank A Fish, et al.
The Lancet. Diabetes & Endocrinology|April 18, 2021
Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trialsGeorge J Kahaly, Raymond S Douglas, Robert J Holt, et al.
JIMD Reports|January 14, 2022
Cysteamine bitartrate delayed-release capsules control leukocyte cystine levels and promote statural growth and kidney health in an open-label study of treatment-naïve patients <6 years of age with nephropathic cystinosisMaria Helena Vaisbich, Juliana Caires Ferreira, Heather Price, et al.
Clinical Pharmacokinetics|March 26, 2021
Pharmacokinetics and Exposure-Response Relationship of Teprotumumab, an Insulin-Like Growth Factor-1 Receptor-Blocking Antibody, in Thyroid Eye DiseaseYan Xin, Fengyan Xu, Yuying Gao, et al.
Hypertension (Dallas, Tex. : 1979)|November 21, 2007
Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedemaJames Brian Byrd, Karine Touzin, Saba Sile, et al.
Human Heredity|July 27, 2007
Haplotype diversity in four genes (CLCNKA, CLCNKB, BSND, NEDD4L) involved in renal salt reabsorptionSaba Sile, Digna R Velez, Niloufar B Gillani, et al.
Journal of Hypertension|February 21, 2009
CLCNKB-T481S and essential hypertension in a Ghanaian populationSaba Sile, Digna R Velez, Niloufar B Gillani, et al.
American Journal of Hypertension|October 24, 2007
Functional BSND variants in essential hypertensionSaba Sile, Niloufar B Gillani, Digna R Velez, et al.
Pageof 2